© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
September 18, 2020
New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.
September 17, 2020
Data from the WHI indicates adverse pregnancy outcomes were associated with increased risk of ASCVD later in life.
September 11, 2020
An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.
September 08, 2020
Paul Thompson, MD, offers perspective on the effects of tamoxifen on triglyceride levels.
September 06, 2020
Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.
September 05, 2020
An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.
September 03, 2020
An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes
August 31, 2020
Analysis of the UK Biobank cohort details associations between increased HbA1c levels and risk of myocardial infarction in patients regardless of sex.
August 27, 2020
A look at nationwide data from an 11-year period gives physicians a greater understanding of predictors, trends, and outcomes associated with stroke in hypertensive disorders of pregnancy.
August 26, 2020
New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.